BioLife Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BLFE research report →
About the company
BioLife Sciences Corp. specializes in the creation, licensing, and distribution of both antibacterial solutions and advanced non-contact human temperature screening technologies. Its diverse product portfolio includes sanitizing wipes, ultraviolet (UV) sterilization equipment, professional electrostatic disinfection services, specialized anti-microbial fabrics, and innovative touch-free vending or marketplace systems.
- CEO
- Justin De Four
- IPO
- 2005
- Employees
- 3
- HQ
- Henderson, ON, CA
Price Chart
- Market Cap
- $156.68K
- P/E
- -0.00
- P/S
- 0.38
- P/B
- -0.01
- EV/EBITDA
- -0.26
- Div Yield
- 0.00%
- Gross Margin
- -239.25%
- Op Margin
- -302.17%
- Net Margin
- -307.99%
- ROE
- 367.14%
- ROIC
- 248.80%
- Revenue
- $411.69K · 0.00%
- Net Income
- $-1,268,000 · -111716.58%
- EPS
- $-0.02 · -24400.00%
- Op Income
- $-1,244,000
- FCF YoY
- -5207564.71%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -2290.12
- Avg Volume
- 178.07K
Get TickerSpark's AI analysis on BLFE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BLFE coverage
Recent articles, reports, and earnings notes.
No research on BLFE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BLFE report →Similar companies
Peers in the same neighborhood.